Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2005-06-14
2005-06-14
Raymond, Richard L. (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S249000, C514S266200, C514S266230, C514S300000, C514S310000, C514S313000, C514S314000, C514S373000, C514S379000, C514S395000, C514S405000, C514S406000, C544S237000, C544S258000, C544S259000, C544S260000, C544S284000, C544S293000, C546S122000, C546S143000, C546S159000, C548S207000, C548S241000, C548S304700, C548S306100, C548S362100, C548S364100, C548S364400
Reexamination Certificate
active
06906070
ABSTRACT:
The present application describes nitrogen containing heteroaromatics and derivatives thereof of formula I:or pharmaceutically acceptable salt forms thereof, wherein rings D-E represent guanidine mimics, which are useful as inhibitors of factor Xa.
REFERENCES:
patent: 5202330 (1993-04-01), Atwal et al.
patent: 5317103 (1994-05-01), Baker et al.
patent: 5342851 (1994-08-01), Sanfilippo et al.
patent: 5463071 (1995-10-01), Himmelsbach et al.
patent: 5616601 (1997-04-01), Khanna et al.
patent: 5681838 (1997-10-01), Zoller et al.
patent: 5707998 (1998-01-01), Takase et al.
patent: 5932576 (1999-08-01), Anantanarayan et al.
patent: 5998424 (1999-12-01), Galemmo et al.
patent: 6020357 (2000-02-01), Pinto et al.
patent: 6403620 (2002-06-01), Galemmo et al.
patent: 234830 (1987-09-01), None
patent: 236902 (1987-09-01), None
patent: 513387 (1992-11-01), None
patent: 554829 (1993-08-01), None
patent: 4247081 (1992-09-01), None
patent: WO 9402477 (1994-02-01), None
patent: WO 9514683 (1995-06-01), None
patent: WO 9518111 (1995-07-01), None
patent: WO 9628427 (1996-09-01), None
patent: WO 9640143 (1996-12-01), None
patent: WO 9723212 (1997-07-01), None
patent: WO 9732583 (1997-09-01), None
Tidwell et al. “Diarylamidine derivatives with one or both of the aryl moieties consisting of an indole or indole-like ring. Inhibitors of arginine-specific esteroproteases”, J. Med. Chem. (1978), 21(7), 613-623.
Clark Charles G.
Dominguez Celia
Fevig John M.
Han Qi
Lam Patrick Y.
Belfield Jing S.
Bristol-Myers Squibb Pharma Company
Raymond Richard L.
Vance David H.
LandOfFree
Guanidine mimics as factor Xa inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Guanidine mimics as factor Xa inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Guanidine mimics as factor Xa inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3518855